Sandra Roche
Impact in
-
- Drug Transport and Resistance Mechanisms
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
-
- Nanoparticle-Based Drug Delivery
Papers in
- Oncology 11
- Pancreatic and Hepatic Oncology Research 5
- HER2/EGFR in Cancer Research 3
-
- Breast Cancer Treatment Studies 4
- MicroRNA in disease regulation 2
- Co-authors
- Robert A. O'Connor (9 shared papers)MARTIN M. CLYNES (11 shared papers)Tsedev Ninjbadgar (1 shared paper)Jean‐Pierre Gillet (1 shared paper)Britta Stordal (1 shared paper)Andreas Heise (1 shared paper)Michael M. Gottesman (1 shared paper)Victoria McEneaney (1 shared paper)
- Journals
- PLoS ONE (4 papers)Journal of Chromatography B (2 papers)Journal of Controlled Release (1 paper)Translational Oncology (1 paper)Journal of Oncology (1 paper)
- Partner nations
- IrelandUnited StatesChina
In The Last Decade
Sandra Roche
23 papers receiving 433 citations
Peers
Comparison fields: 5 of 53
- Oncology 136
- Biomaterials 55
- Cancer Research 52
- Analytical Chemistry 33
- Reproductive Medicine 22
Countries citing papers authored by Sandra Roche
This map shows the geographic impact of Sandra Roche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Roche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Roche more than expected).
Fields of papers citing papers by Sandra Roche
This network shows the impact of papers produced by Sandra Roche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Roche. The network helps show where Sandra Roche may publish in the future.
Co-authors
The 25 scholars most cited alongside Sandra Roche, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 82 | |
| 2 | 2012 | 80 | |
| 3 | 2009 | 41 | |
| 4 | 2020 | 35 | |
| 5 | 2015 | 29 | |
| 6 | 2020 | 28 | |
| 7 | 2020 | 24 | |
| 8 | 2018 | 23 | |
| 9 | 2019 | 20 | |
| 10 | 2010 | 18 | |
| 11 | 2020 | 14 | |
| 12 | 2012 | 11 | |
| 13 | 2020 | 7 | |
| 14 | 2020 | 6 | |
| 15 | 2023 | 6 | |
| 16 | 2017 | 3 | |
| 17 | 2022 | 3 | |
| 18 | 2023 | 3 | |
| 19 | 2024 | 3 | |
| 20 | 2022 | 2 |
About Sandra Roche
Sandra Roche is a scholar working on Oncology, Cancer Research, Analytical Chemistry, Biomaterials and Endocrinology, Diabetes and Metabolism, having authored 23 papers that have together received 441 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (5 papers), Breast Cancer Treatment Studies (4 papers), HER2/EGFR in Cancer Research (3 papers), Analytical Methods in Pharmaceuticals (2 papers), Nanoparticle-Based Drug Delivery (2 papers), MicroRNA in disease regulation (2 papers), Lung Cancer Diagnosis and Treatment (2 papers) and Growth Hormone and Insulin-like Growth Factors (2 papers). The work is most often cited by research in Oncology (136 citations), Biomaterials (55 citations), Cancer Research (52 citations), Analytical Chemistry (33 citations) and Reproductive Medicine (22 citations). Sandra Roche has collaborated with scholars based in Ireland, United States and China. Frequent co-authors include Robert A. O'Connor, MARTIN M. CLYNES, Tsedev Ninjbadgar, Jean‐Pierre Gillet, Britta Stordal, Andreas Heise, Michael M. Gottesman, Victoria McEneaney, Dermot F. Brougham and John J. O’Leary. Their work appears in journals such as PLoS ONE, Journal of Chromatography B, Journal of Controlled Release, Translational Oncology and Journal of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.